Polar Capital Holdings’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Sell |
|
|||||
|
2025
Q1 | $25.5M | Sell |
|
|||||
|
2024
Q4 | $39.6M | Sell |
|
|||||
|
2024
Q3 | $92.5M | Sell |
|
|||||
|
2024
Q2 | $114M | Buy |
|
|||||
|
2024
Q1 | $128M | Sell |
|
|||||
|
2023
Q4 | $124M | Buy |
|
|||||
|
2023
Q3 | $66.8M | Buy |
|
|||||
|
2023
Q2 | $82M | Buy |
|
|||||
|
2023
Q1 | $81.6M | Buy |
|
|||||
|
2022
Q4 | $69.1M | Buy |
|
|||||
|
2022
Q3 | $40.7K | Buy |
|
|||||
|
2022
Q2 | $17.5K | Sell |
|
|||||
|
2022
Q1 | $42.6K | Buy |
|
|||||
|
2021
Q4 | $38.6K | Buy |
|
|||||
|
2021
Q3 | $39K | Buy |
|
|||||
|
2021
Q2 | $16.7K | Hold |
|
|||||
|
2021
Q1 | $10.3M | Sell |
|
|||||
|
2020
Q4 | $17.5M | Buy |
|